1. Home
  2. GRDN vs HAE Comparison

GRDN vs HAE Comparison

Compare GRDN & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardian Pharmacy Services Inc.

GRDN

Guardian Pharmacy Services Inc.

HOLD

Current Price

$37.00

Market Cap

2.4B

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$61.89

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRDN
HAE
Founded
2004
1971
Country
United States
United States
Employees
3600
N/A
Industry
Retail-Drug Stores and Proprietary Stores
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.6B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
GRDN
HAE
Price
$37.00
$61.89
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$40.25
$84.13
AVG Volume (30 Days)
563.6K
546.0K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
44.54
EPS
N/A
2.46
Revenue
N/A
$910,373,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.63
$5.23
P/E Ratio
$117.77
$24.55
Revenue Growth
N/A
N/A
52 Week Low
$19.17
$47.32
52 Week High
$41.36
$87.32

Technical Indicators

Market Signals
Indicator
GRDN
HAE
Relative Strength Index (RSI) 50.79 60.34
Support Level $28.07 $48.47
Resistance Level $37.78 $66.86
Average True Range (ATR) 1.48 1.77
MACD -0.14 0.75
Stochastic Oscillator 40.32 98.19

Price Performance

Historical Comparison
GRDN
HAE

About GRDN Guardian Pharmacy Services Inc.

Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: